Original Research

Page 52

Posts about this type

Original Research

Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis: Twelve-Month Outcome

April 15, 2013

Patrick D. McGorry, Barnaby Nelson, Lisa J. Phillips, et al

Original Research

Severe Neuropsychiatric Outcomes Following Discontinuation of Long-Term Glucocorticoid Therapy: A Cohort Study

April 15, 2013

Laurence Fardet, Irwin Nazareth, Heather J. Whitaker, et al

Original Research

The Type 2 Diabetes Mellitus Susceptibility Gene IGF2BP2 Is Associated With Schizophrenia in a Han Chinese Population

April 15, 2013

Xuan Zhang, Li Hui, Yang Liu, et al

Original Research

Safety and Efficacy of Methylphenidate for Apathy in Alzheimer's Disease: A Randomized, Placebo-Controlled Trial

April 3, 2013

Paul B. Rosenberg, Krista L. LanctÃ´t, Lea T. Drye, et al

Original Research

Co-Occurrence of Major Depressive Episode and Posttraumatic Stress Disorder Among Survivors of War: How Is It Different From Either Condition Alone?

March 15, 2013

Nexhmedin Morina, Dean Ajdukovic, Marija Bogic, et al

Original Research

Efficacy and Safety of Levomilnacipran Sustained Release 40 mg, 80 mg, or 120 mg in Major Depressive Disorder: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study

March 15, 2013

Gregory M. Asnis, Anjana Bose, Carl P. Gommoll, et al

Original Research

Extreme Attributions Predict the Course of Bipolar Depression: Results From the STEP-BD Randomized Controlled Trial of Psychosocial Treatment

March 15, 2013

Jonathan P. Stange, Louisa G. Sylvia, Pedro Vieira da Silva MagalhÃ£es, et al

Original Research

Posttraumatic Stress Disorder in Adult Attention-Deficit/Hyperactivity Disorder: Clinical Features and Familial Transmission

March 15, 2013

Kevin M. Antshel, Prashant Kaul, Joseph Biederman, et al

Original Research

Recovery From Multiple Episodes of Bipolar I Depression

March 15, 2013

David A. Solomon, Jess G. Fiedorowicz, Andrew C. Leon, et al

Original Research

Sexual Satisfaction and Quality of Life in Major Depressive Disorder Before and After Treatment With Citalopram in the STAR*D Study

March 15, 2013

Waguih William IsHak, Scott Christensen, Gregory Sayer, et al

Original Research

Suicide Risk Assessment Received Prior to Suicide Death by Veterans Health Administration Patients With a History of Depression

March 15, 2013

Eric G. Smith, Hyungjin Myra Kim, Dara Ganoczy, et al

Original Research

Cytochrome P450 2D6 Phenoconversion Is Common in Patients Being Treated for Depression: Implications for Personalized Medicine

March 13, 2013

Sheldon H. Preskorn, Cecelia P. Kane, Kasia Lobello, et al

Original Research

Effectiveness of Lurasidone for Patients With Schizophrenia Following 6 Weeks of Acute Treatment With Lurasidone, Olanzapine, or Placebo: A 6-Month, Open-Label, Extension Study

March 13, 2013

Stephen M. Stahl, Josephine Cucchiaro, Doreen Simonelli, et al

Original Research

Mindfulness Meditation for Anxiety

March 13, 2013

Read a randomized controlled on the Trial of Mindfulness Meditation for Generalized Anxiety Disorder and the Effects on Anxiety and Stress Reactivity.

Elizabeth A. Hoge, Eric Bui, Luana Marques, et al

Original Research

Disability After Injury: The Cumulative Burden of Physical and Mental Health

February 15, 2013

Meaghan L. O' Donnell, Tracey Varker, Alexander C. Holmes, et al

Original Research

Effects of Cigarette Smoking on Neuropsychological Performance in Mood Disorders: A Comparison Between Smoking and Nonsmoking Inpatients

February 15, 2013

Daniela Caldirola, Silvia Daccò, Massimiliano Grassi, et al

Original Research

Efficacy and Safety of Desvenlafaxine 50 mg/d for Prevention of Relapse in Major Depressive Disorder: A Randomized Controlled Trial

February 15, 2013

Joshua Z. Rosenthal, Patrice Boyer, Cécile Vialet, et al

Original Research

Antipsychotic Drugs, Mood Stabilizers, and Risk of Pneumonia in Bipolar Disorder: A Nationwide Case-Control Study

January 15, 2013

Shu-Yu Yang, Ya-Tang Liao, Hsing-Cheng Liu, et al

Original Research

Effectiveness of Lurasidone in Patients with Schizophrenia or Schizoaffective Disorder Switched From Other Antipsychotics: A Randomized, 6-Week, Open-Label Study

January 15, 2013

Joseph P. McEvoy, Leslie Citrome, David Hernandez, et al

Original Research

Four-Year Outcome in Psychopharmacologically Treated Adults With Attention-Deficit/Hyperactivity Disorder: A Questionnaire Survey

January 15, 2013

Michael B. Lensing, Pål Zeiner, Leiv Sandvik, et al

Original Research

Quantitative Electroencephalogram Biomarkers for Predicting Likelihood and Speed of Achieving Sustained Remission in Major Depression: A Report From the Biomarkers for Rapid Identification of Treatment Effectiveness in Major Depression (BRITE-MD) Trial

January 15, 2013

Ian A. Cook, Aimee M. Hunter, William S. Gilmer, et al

Original Research

Substance Induced Schizophrenia

January 15, 2013

Read a study investigating the rate of SIP conversion to schizophrenia spectrum disorder.

Jussi A. Niemi-Pynttärin, Reijo Sund, Hanna Putkonen, et al

Original Research

Trends in Office-Based Treatment of Adults With Stimulants in the United States

January 15, 2013

Mark Olfson, Carlos Blanco, Shuai Wang, et al

Original Research

The Daytime Impactof DSM-5 Insomnia Disorder: Comparative Analysis of Insomnia Subtypes From the Great British Sleep Survey

December 15, 2012

Colin A. Espie, Simon D. Kyle, Peter Hames, et al

« 1 … 50 51 52 53 54 … 157 »

Original Research

Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis: Twelve-Month Outcome

Severe Neuropsychiatric Outcomes Following Discontinuation of Long-Term Glucocorticoid Therapy: A Cohort Study

The Type 2 Diabetes Mellitus Susceptibility Gene IGF2BP2 Is Associated With Schizophrenia in a Han Chinese Population

Safety and Efficacy of Methylphenidate for Apathy in Alzheimer's Disease: A Randomized, Placebo-Controlled Trial

Co-Occurrence of Major Depressive Episode and Posttraumatic Stress Disorder Among Survivors of War: How Is It Different From Either Condition Alone?

Efficacy and Safety of Levomilnacipran Sustained Release 40 mg, 80 mg, or 120 mg in Major Depressive Disorder: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study

Extreme Attributions Predict the Course of Bipolar Depression: Results From the STEP-BD Randomized Controlled Trial of Psychosocial Treatment

Posttraumatic Stress Disorder in Adult Attention-Deficit/Hyperactivity Disorder: Clinical Features and Familial Transmission

Recovery From Multiple Episodes of Bipolar I Depression

Sexual Satisfaction and Quality of Life in Major Depressive Disorder Before and After Treatment With Citalopram in the STAR*D Study

Suicide Risk Assessment Received Prior to Suicide Death by Veterans Health Administration Patients With a History of Depression

Cytochrome P450 2D6 Phenoconversion Is Common in Patients Being Treated for Depression: Implications for Personalized Medicine

Effectiveness of Lurasidone for Patients With Schizophrenia Following 6 Weeks of Acute Treatment With Lurasidone, Olanzapine, or Placebo: A 6-Month, Open-Label, Extension Study

Mindfulness Meditation for Anxiety

Disability After Injury: The Cumulative Burden of Physical and Mental Health

Effects of Cigarette Smoking on Neuropsychological Performance in Mood Disorders: A Comparison Between Smoking and Nonsmoking Inpatients

Efficacy and Safety of Desvenlafaxine 50 mg/d for Prevention of Relapse in Major Depressive Disorder: A Randomized Controlled Trial

Antipsychotic Drugs, Mood Stabilizers, and Risk of Pneumonia in Bipolar Disorder: A Nationwide Case-Control Study

Effectiveness of Lurasidone in Patients with Schizophrenia or Schizoaffective Disorder Switched From Other Antipsychotics: A Randomized, 6-Week, Open-Label Study

Four-Year Outcome in Psychopharmacologically Treated Adults With Attention-Deficit/Hyperactivity Disorder: A Questionnaire Survey

Quantitative Electroencephalogram Biomarkers for Predicting Likelihood and Speed of Achieving Sustained Remission in Major Depression: A Report From the Biomarkers for Rapid Identification of Treatment Effectiveness in Major Depression (BRITE-MD) Trial

Substance Induced Schizophrenia

Trends in Office-Based Treatment of Adults With Stimulants in the United States

The Daytime Impactof DSM-5 Insomnia Disorder: Comparative Analysis of Insomnia Subtypes From the Great British Sleep Survey

ELSEWHERE:

FOLLOW US:

Original Research

Posts about this type

Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis: Twelve-Month Outcome

Severe Neuropsychiatric Outcomes Following Discontinuation of Long-Term Glucocorticoid Therapy: A Cohort Study

The Type 2 Diabetes Mellitus Susceptibility Gene IGF2BP2 Is Associated With Schizophrenia in a Han Chinese Population

Safety and Efficacy of Methylphenidate for Apathy in Alzheimer's Disease: A Randomized, Placebo-Controlled Trial

Co-Occurrence of Major Depressive Episode and Posttraumatic Stress Disorder Among Survivors of War: How Is It Different From Either Condition Alone?

Efficacy and Safety of Levomilnacipran Sustained Release 40 mg, 80 mg, or 120 mg in Major Depressive Disorder: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study

Extreme Attributions Predict the Course of Bipolar Depression: Results From the STEP-BD Randomized Controlled Trial of Psychosocial Treatment

Posttraumatic Stress Disorder in Adult Attention-Deficit/Hyperactivity Disorder: Clinical Features and Familial Transmission

Recovery From Multiple Episodes of Bipolar I Depression

Sexual Satisfaction and Quality of Life in Major Depressive Disorder Before and After Treatment With Citalopram in the STAR*D Study

Suicide Risk Assessment Received Prior to Suicide Death by Veterans Health Administration Patients With a History of Depression

Cytochrome P450 2D6 Phenoconversion Is Common in Patients Being Treated for Depression: Implications for Personalized Medicine

Effectiveness of Lurasidone for Patients With Schizophrenia Following 6 Weeks of Acute Treatment With Lurasidone, Olanzapine, or Placebo: A 6-Month, Open-Label, Extension Study

Mindfulness Meditation for Anxiety

Disability After Injury: The Cumulative Burden of Physical and Mental Health

Effects of Cigarette Smoking on Neuropsychological Performance in Mood Disorders: A Comparison Between Smoking and Nonsmoking Inpatients

Efficacy and Safety of Desvenlafaxine 50 mg/d for Prevention of Relapse in Major Depressive Disorder: A Randomized Controlled Trial

Antipsychotic Drugs, Mood Stabilizers, and Risk of Pneumonia in Bipolar Disorder: A Nationwide Case-Control Study

Effectiveness of Lurasidone in Patients with Schizophrenia or Schizoaffective Disorder Switched From Other Antipsychotics: A Randomized, 6-Week, Open-Label Study

Four-Year Outcome in Psychopharmacologically Treated Adults With Attention-Deficit/Hyperactivity Disorder: A Questionnaire Survey

Quantitative Electroencephalogram Biomarkers for Predicting Likelihood and Speed of Achieving Sustained Remission in Major Depression: A Report From the Biomarkers for Rapid Identification of Treatment Effectiveness in Major Depression (BRITE-MD) Trial

Substance Induced Schizophrenia

Trends in Office-Based Treatment of Adults With Stimulants in the United States

The Daytime Impactof DSM-5 Insomnia Disorder: Comparative Analysis of Insomnia Subtypes From the Great British Sleep Survey

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles